Skip to content

A clinical trial to study the effects of Ayurvedic drug in patients with type 2 diabetes mellitus.

To Evaluate the safety and Efficacy of Divine Noni Gold In Type II Diabetes Mellitus

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/10/002044
Enrollment
60
Registered
2011-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type II Diabetes mellitus

Interventions

Intervention1: Divine Noni Gold: Dosage:1. First 3 days 5 ml twice daily, on an empty stomach(Morn and Even) 2.Next 3 days 10 ml twice daily, on an empty stomach.(Morn and Even) 3.Seventh day onward

Sponsors

Noni BioTech Private Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with impaired blood sugar with no other systemic diseases are included in the trial.sample size-60

Exclusion criteria

Exclusion criteria: Malignancy Pregnancy Breast feeding Hypersensitivity reactions active liver disease or hepatic dysfunction Serious or unstable medical or psychological condition Impaired renal function History of serious adverse effects

Design outcomes

Primary

MeasureTime frame
Improvement in the Laboratory Investigations showing control in the blood sugar levels.Symptometic relief to be notified.Timepoint: 3 months

Secondary

MeasureTime frame
Complaince of the patient to the drug treatment and any adverse effects will be notedTimepoint: 3 months

Countries

India

Contacts

Public ContactProfK V Peter PhDFNAASFNASc

Department of AYUSH,NewDelhi and The T.N.Dr.M.G.R.Medical University,Chennai

principal.ayur@saimedical.com09176677750

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026